BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32638131)

  • 21. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
    Chen CG; Cui L; Tang P; Yu ZT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
    Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
    Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
    Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
    J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synchronous triple primary cancers of the pharynx and esophagus.
    Kataoka S; Omae M; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T; Fujisaki J; Yamada K; Igarashi M
    Clin J Gastroenterol; 2017 Jun; 10(3):208-213. PubMed ID: 28315155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk patterns of subsequent primary cancers following esophagectomy in early-stage thoracic esophageal squamous cell cancer patients.
    Hu WS; Liu ZJ; Zhang JB; Wang ZL; Yang N; Xu L; Tian H; Zhang PL
    Tumori; 2015; 101(3):328-33. PubMed ID: 25908032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus.
    Fahn HJ; Wang LS; Huang BS; Huang MH; Chien KY
    Ann Thorac Surg; 1994 Mar; 57(3):677-81. PubMed ID: 8147640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary mucoepidermoid carcinoma of the esophagus.
    Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
    J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric tube reconstruction of esophagus for esophageal and stomach carcinomas.
    Kwon JS; Kim JB; Cho KB; Kim ES; Park KS; Park CK
    Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):600-3. PubMed ID: 23087311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the short-term and long-term outcomes of surgical treatment versus endoscopic treatment for early esophageal squamous cell neoplasia larger than 2 cm: a retrospective study.
    Yuan B; Liu L; Huang H; Li D; Shen Y; Wu B; Liu J; Yang M; Wang Z; Lu H; Liu Y; Liao L; Wang F
    Surg Endosc; 2019 Jul; 33(7):2304-2312. PubMed ID: 30361966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ivor-Lewis esophagectomy for patients with squamous cell carcinoma of the thoracic esophagus with a history of total pharyngolaryngectomy.
    Takahashi K; Mine S; Kozuki R; Toihata T; Okamura A; Imamura Y; Watanabe M
    Esophagus; 2019 Oct; 16(4):382-385. PubMed ID: 31104160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment.
    Matsuda S; Takeuchi H; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Dis Esophagus; 2014; 27(7):654-61. PubMed ID: 23980622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
    Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
    Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinoma.
    Katada C; Muto M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Masaki T; Nakayama M; Okamoto M; Koizumi W
    Dig Endosc; 2013 Mar; 25 Suppl 1():39-43. PubMed ID: 23480401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
    Shim YM; Park JS; Lee M; Kim D; Kim K
    Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
    Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
    Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison.
    Plum PS; Hölscher AH; Pacheco Godoy K; Schmidt H; Berlth F; Chon SH; Alakus H; Bollschweiler E
    Surg Endosc; 2018 Sep; 32(9):3972-3980. PubMed ID: 29536160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
    Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
    Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The total number of resected lymph node is not a prognostic factor for recurrence in esophageal squamous cell carcinoma patients undergone transthoracic esophagectomy.
    Hsu PK; Wang BY; Chou TY; Huang CS; Wu YC; Hsu WH
    J Surg Oncol; 2011 Apr; 103(5):416-20. PubMed ID: 21400526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.